Literature DB >> 14713718

T-cell anergy: from phenotype to genotype and back.

Christine M Seroogy1, C Garrison Fathman.   

Abstract

For many decades, anergy has been used as a descriptive term to describe a state of antigen-specific unresponsiveness. A better understanding of this phenotype was revealed in the 1980s using in vitro model systems. These model systems demonstrated that protein synthesis and mobilization of Ca2+ was required leading to the pursuit of a novel gene(s) that would be unique to the anergy phenotype. Several putative "anergy factors" have been suggested. In this review, we provide an overview of the anergy phenotype and proposed anergy-related genes. To date, no single gene has been described that would completely fulfill the criteria of an "anergy factor." We review work from our laboratory describing a novel gene that we have termed Gene Related to Anergy In Lymphocytes (GRAIL) that is upregulated in T cells anergized in vitro and in vivo and, following transduction into T cells, reiterates the anergy phenotype.

Entities:  

Mesh:

Year:  2003        PMID: 14713718     DOI: 10.1385/IR:28:3:255

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  32 in total

1.  CTLA-4 regulates induction of anergy in vivo.

Authors:  R J Greenwald; V A Boussiotis; R B Lorsbach; A K Abbas; A H Sharpe
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

2.  Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation.

Authors:  C Tanchot; D L Barber; L Chiodetti; R H Schwartz
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

3.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

4.  TCR engagement in the absence of cell cycle progression leads to T cell anergy independent of p27(Kip1).

Authors:  J D Powell; D Bruniquel; R H Schwartz
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

5.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Authors:  D Tzachanis; G J Freeman; N Hirano; A A van Puijenbroek; M W Delfs; A Berezovskaya; L M Nadler; V A Boussiotis
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

6.  The C-class chemokine lymphotactin costimulates the apoptosis of human CD4(+) T cells.

Authors:  C Cerdan; E Devilard; L Xerri; D Olive
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

7.  The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade.

Authors:  Peter Blaha; Sinda Bigenzahn; Zvonimir Koporc; Maximilian Schmid; Felix Langer; Edgar Selzer; Helga Bergmeister; Friedrich Wrba; Josef Kurtz; Christopher Kiss; Erich Roth; Ferdinand Muehlbacher; Megan Sykes; Thomas Wekerle
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

8.  Hierarchical signaling thresholds determine the fates of naíve T cells: partial priming leads nai;ve T cells to unresponsiveness.

Authors:  Hiromichi Yamashiro; Yo Odani; Nobumichi Hozumi; Naoko Nakano
Journal:  Biochem Biophys Res Commun       Date:  2002-11-22       Impact factor: 3.575

9.  Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling.

Authors:  Eric Sebzda; Madelon Bracke; Tamara Tugal; Nancy Hogg; Doreen Ann Cantrell
Journal:  Nat Immunol       Date:  2002-02-11       Impact factor: 25.606

10.  In vivo anergized CD4+ T cells have defective expression and function of the activating protein-1 transcription factor.

Authors:  A Sundstedt; M Dohlsten
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

View more
  4 in total

1.  Transcriptional modulation of TCR, Notch and Wnt signaling pathways in SEB-anergized CD4+ T cells.

Authors:  S Kurella; J C Yaciuk; I Dozmorov; M B Frank; M Centola; A D Farris
Journal:  Genes Immun       Date:  2005-10       Impact factor: 2.676

2.  Upregulation of GRAIL is associated with impaired CD4 T cell proliferation in sepsis.

Authors:  Monowar Aziz; Weng-Lang Yang; Shingo Matsuo; Archna Sharma; Mian Zhou; Ping Wang
Journal:  J Immunol       Date:  2014-01-29       Impact factor: 5.422

3.  GRAIL and Otubain-1 are Related to T Cell Hyporesponsiveness during Trypanosoma cruzi Infection.

Authors:  Cinthia C Stempin; Jorge D Rojas Marquez; Yamile Ana; Fabio M Cerban
Journal:  PLoS Negl Trop Dis       Date:  2017-01-23

Review 4.  Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy.

Authors:  Xia Liu; Daniel F Hoft; Guangyong Peng
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.